Lv11
10 积分 2022-03-29 加入
The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies
6小时前
待确认
Characterization of circRNAs in established osimertinib‑resistant non‑small cell lung cancer cell lines
23天前
已完结
CircMYBL1 suppressed acquired resistance to osimertinib in non-small-cell lung cancer
23天前
已完结
CircMYBL1 suppressed acquired resistance to osimertinib in non-small-cell lung cancer
3个月前
已完结
CircPOLA2 sensitizes non-small cell lung cancer cells to ferroptosis and suppresses tumorigenesis via the Merlin-YAP signaling pathway
3个月前
已完结
CircLIFRSA/miR-1305/PTEN axis attenuates malignant cellular processes in non-small cell lung cancer by regulating AKT phosphorylation
3个月前
已完结
circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC)
5个月前
已完结
Neutrophil Targeting Platform Reduces Neutrophil Extracellular Traps for Improved Traumatic Brain Injury and Stroke Theranostics
5个月前
已完结
Hepatocyte-derived FGL1 accelerates liver metastasis and tumor growth by inhibiting CD8+ T and NK cells
6个月前
已关闭
Loss of Key EMT-Regulating miRNAs Highlight the Role of ZEB1 in EGFR Tyrosine Kinase Inhibitor-Resistant NSCLC
7个月前
已完结
皖公网安备34019202002308
